Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 19624457)

1.

Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model.

Carneiro-Lobo TC, Konig S, Machado DE, Nasciutti LE, Forni MF, Francischetti IM, Sogayar MC, Monteiro RQ.

J Thromb Haemost. 2009 Nov;7(11):1855-64. doi: 10.1111/j.1538-7836.2009.03553.x. Epub 2009 Jul 17.

2.

99mTc-ixolaris targets glioblastoma-associated tissue factor: In vitro and pre-clinical applications.

Barboza T, Gomes T, Mizurini DM, Monteiro RQ, König S, Francischetti IM, Signoretti PV, Ramos IP, Gutfilen B, Souza SA.

Thromb Res. 2015 Jun 6. pii: S0049-3848(15)30011-6. doi: 10.1016/j.thromres.2015.05.032. [Epub ahead of print]

PMID:
26070446
3.

Mammalian diaphanous-related formin 1 is required for motility and invadopodia formation in human U87 glioblastoma cells.

Li Z, Xu Y, Zhang C, Liu X, Jiang L, Chen F.

Int J Mol Med. 2014 Feb;33(2):383-91. doi: 10.3892/ijmm.2013.1577. Epub 2013 Dec 5.

PMID:
24317603
4.

Expression of tissue factor signaling pathway elements correlates with the production of vascular endothelial growth factor and interleukin-8 in human astrocytoma patients.

Carneiro-Lobo TC, Lima MT, Mariano-Oliveira A, Dutra-Oliveira A, Oba-Shinjo SM, Marie SK, Sogayar MC, Monteiro RQ.

Oncol Rep. 2014 Feb;31(2):679-86. doi: 10.3892/or.2013.2880. Epub 2013 Nov 28.

PMID:
24297570
5.

Dynamic quantitative intravital imaging of glioblastoma progression reveals a lack of correlation between tumor growth and blood vessel density.

Ricard C, Stanchi F, Rodriguez T, Amoureux MC, Rougon G, Debarbieux F.

PLoS One. 2013 Sep 12;8(9):e72655. doi: 10.1371/journal.pone.0072655. eCollection 2013.

6.

Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression.

Mammoto T, Jiang A, Jiang E, Panigrahy D, Kieran MW, Mammoto A.

Am J Pathol. 2013 Oct;183(4):1293-305. doi: 10.1016/j.ajpath.2013.06.026. Epub 2013 Aug 5.

7.

Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.

Xiong J, Yang Q, Li J, Zhou S.

Angiogenesis. 2014 Jan;17(1):37-50. doi: 10.1007/s10456-013-9376-3. Epub 2013 Aug 2.

PMID:
23907365
8.

Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition.

Piao Y, Liang J, Holmes L, Henry V, Sulman E, de Groot JF.

Clin Cancer Res. 2013 Aug 15;19(16):4392-403. doi: 10.1158/1078-0432.CCR-12-1557. Epub 2013 Jun 26.

9.

Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.

Lin W, Zheng L, Zhuang Q, Zhao J, Cao Z, Zeng J, Lin S, Xu W, Peng J.

BMC Complement Altern Med. 2013 Jun 24;13:144. doi: 10.1186/1472-6882-13-144.

10.
11.

Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model.

Harter PN, Dützmann S, Drott U, Zachskorn C, Hattingen E, Capper D, Gessler F, Senft C, Seifert V, Plate KH, Kögel D, Mittelbronn M.

Neuropathology. 2013 Oct;33(5):515-25. doi: 10.1111/neup.12018. Epub 2013 Feb 5.

PMID:
23384223
12.

Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide.

Golubovskaya VM, Huang G, Ho B, Yemma M, Morrison CD, Lee J, Eliceiri BP, Cance WG.

Mol Cancer Ther. 2013 Feb;12(2):162-72. doi: 10.1158/1535-7163.MCT-12-0701. Epub 2012 Dec 12.

13.

Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo.

Nakabayashi H, Shimizu K.

BMC Cancer. 2012 Oct 5;12:453. doi: 10.1186/1471-2407-12-453.

14.

Tissue factor regulates tumor angiogenesis of retinoblastoma via the extracellular signal-regulated kinase pathway.

Song HB, Park KD, Kim JH, Kim DH, Yu YS, Kim JH.

Oncol Rep. 2012 Dec;28(6):2057-62. doi: 10.3892/or.2012.2048. Epub 2012 Sep 20.

PMID:
23007470
15.

Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.

Piao Y, Liang J, Holmes L, Zurita AJ, Henry V, Heymach JV, de Groot JF.

Neuro Oncol. 2012 Nov;14(11):1379-92. doi: 10.1093/neuonc/nos158. Epub 2012 Sep 10.

16.

Targeting c-Myc on cell growth and vascular endothelial growth factor expression in IN500 glioblastoma cells.

Hu YH, Kong SQ, Kong HB, Wu JL, Chen Z.

Chin Med J (Engl). 2012 Jun;125(11):2025-31.

PMID:
22884072
17.

Gamma-secretase inhibitor DAPT suppresses glioblastoma growth via uncoupling of tumor vessel density from vessel function.

Zou Y, Cao Y, Yue Z, Liu J.

Clin Exp Med. 2013 Nov;13(4):271-8. doi: 10.1007/s10238-012-0203-8. Epub 2012 Jul 27.

PMID:
22836313
18.

The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.

Carneiro-Lobo TC, Schaffner F, Disse J, Ostergaard H, Francischetti IM, Monteiro RQ, Ruf W.

J Thromb Haemost. 2012 Sep;10(9):1849-58. doi: 10.1111/j.1538-7836.2012.04864.x.

19.

The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.

Bernard H, Garmy-Susini B, Ainaoui N, Van Den Berghe L, Peurichard A, Javerzat S, Bikfalvi A, Lane DP, Bourdon JC, Prats AC.

Oncogene. 2013 Apr 25;32(17):2150-60. doi: 10.1038/onc.2012.242. Epub 2012 Jun 25.

PMID:
22733133
20.

Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma.

de Oliveira Ada S, Lima LG, Mariano-Oliveira A, Machado DE, Nasciutti LE, Andersen JF, Petersen LC, Francischetti IM, Monteiro RQ.

Thromb Res. 2012 Sep;130(3):e163-70. doi: 10.1016/j.thromres.2012.05.021. Epub 2012 Jun 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk